Healthcare ❯Pharmaceuticals

Drug Approval Process

FDA Regulations New Drug Application Mifeprex Food and Drug Administration Rare Diseases

FDA Declines MDMA for PTSD Treatment, Requests Further Trials

The decision marks the first time the agency has considered a Schedule I psychedelic for medical use, highlighting ethical and safety concerns.

FDA Approves Merck's Winrevair for Rare Lung Disease